Stock Price
647.20
Daily Change
1.40 0.22%
Monthly
0.43%
Yearly
20.57%
Q2 Forecast
630.50

argenx SE reported $387.05M in EBITDA for its fiscal quarter ending in September of 2025.





Ebitda Change Date
AstraZeneca USD 5.23B 272M Sep/2025
Galapagos EUR 2.42M 161.13M Sep/2025
Genmab DKK 186M 291M Dec/2025
GlaxoSmithKline GBP 3.36B 179M Sep/2025
GRIFOLS EUR 347.24M 58.35M Jun/2025
Hikma Pharmaceutical USD 369M 84M Dec/2024
Qiagen NV USD 249.69M 56.53M Dec/2025
UCB EUR 1.6B 570M Dec/2025